Lupus Science and Medicine podcast Podcast Episodes Online

Loading podcasts

Fetching podcast shows and categories...

Loading page

Opening Radio and Podcast...

Ready2SERAustralia · College Radio, World Music

Live--:--

Lupus Science and Medicine podcast Podcast Episodes Online | Radio and Podcast

Episodes

50 of 60 episodes

Making Sense of Severe Lupus: How the SLE-DAS Tool Could Improve Care Outcomes

In this episode of the Lupus Foundation of America podcast, Jaren Crump sits down with Dr. Luís Inês, rheumatologist and President of the Eu...

17:20Aug 4, 2025

Inside Lupus: The Potential of Genetic Endotypes to Personalize Lupus Care

In this episode of the Lupus Science and Medicine Podcast, host Dr. Anna Wolska speaks with Dr. Amerie Grammer about how genetic breakthroug...

15:40Jul 7, 2025

Empowering Lupus Patients: A Treatment Measure Shaped by Their Voices

In this podcast, Dr. Anna Wolska sits down with Dr. Eric Morand to discuss a groundbreaking effort to improve how lupus treatment success is...

18:27May 7, 2025

Steroid Use for the Treatment of Lupus Nephritis

Lupus nephritis, affecting nearly half of lupus patients, can cause severe kidney damage. Traditionally, high-dose glucocorticoids (~1 mg pe...

12:15Apr 7, 2025

Validating Claims Algorithms for SLE: Geospatial Insights and Impacts on Health Disparities

Join Dr. Anna Wolska from the Lupus Foundation of America as she talks with Dr. Jim Oates about his recently published study in Lupus Scienc...

13:49Mar 3, 2025

Rethinking Lupus Nephritis Treatment: Voclosporin vs. High-Dose Steroids

Early reduction in proteinuria is a key predictor of improved long-term kidney health in lupus nephritis (LN). In this episode, Dr. Anna Wol...

45:40Feb 3, 2025

Rituximab in Childhood Lupus: Insights and Safety

Join Dr. Anna Wolska and Dr. Jordan Roberts, a pediatric rheumatologist, as they explore the use of Rituximab in treating childhood-onset sy...

15:12Jan 6, 2025

Managing Pregnancy in Lupus: Contraception Use and Beyond

In this episode of the Lupus Science and Medicine podcast, Dr. Megan Clowse, a rheumatologist at Duke University, discusses her research on...

25:51Oct 7, 2024

Leveraging Positive Psychosocial Factors to Manage Stress in Lupus

Join host Dr. Anna Wolska as she explores a new study in Lupus Science & Medicine on how positive psychosocial factors—such as resilience, s...

24:06Sep 2, 2024

Krill Oil may represent a promising complementary therapy in SLE

Join Dr. Anna Wloska from the Lupus foundation of America and Drs. Peter Lipsky and Amerie Grammer as they discuss the effectivenss of krill...

24:24Aug 5, 2024

Understanding the Critical Role of Lupus Clinical Trial Outcome Measures in Advancing Therapeutic Development

Join Dr. Anna Wolska from the Lupus Foundation of America and Dr. Laurent Arnaud, Professor of Rheumatology at the Department of Rheumatolog...

19:43Jul 1, 2024

Interpreting Hydroxychloroquine Blood Levels in Lupus

Join Dr. Anna Wolska from the Lupus Foundation of America as she delves into a groundbreaking discussion with Dr. Stephen Balevic focused on...

20:29Jun 3, 2024

Use of Artificial Intelligence and Machine Learning in Clinical Practice

Join Dr. Anna Wolska and Dr. May Choi as they explore the role of Artificial Intelligence (AI) and Machine Learning (ML) in guiding diagnost...

11:51May 6, 2024

To RNase or Not to RNase: That Is the Question

Join Dr. Anna Wolska and Dr. Jim Posada as they delve into the intricacies of RNAse therapy in the management of Systemic Lupus Erythematosu...

14:05Mar 4, 2024

A decision-aid facilitates patient understanding of benefits vs. risk of hydroxychloriquine use as part of routine care for lupus

Dr. Anna Wolska engages in a conversation with Dr. Shivani Garg and Dr. Christie Bartels to delve into the development and implementation of...

15:05Feb 5, 2024

Dual dsDNA testing may be needed to fully understand patient disease status

Dr. Anna Wolska speaks to Dr. Michael Belmont and Devyn Zaminski to discuss the importance of dual dsDNA testing in order to full understand...

21:40Jan 1, 2024

Is Anifrolumab an effective treatment for lupus nephritis?

Dr. Anna Wolska engages in a discussion with renowned experts, Dr. Catharina Lindholm and Dr. David Jayne, to explore findings from the phas...

12:44Dec 4, 2023

Which one is better at controlling lupus: Belimumab or Anifrolumab?

Dr. Anna Wolska sits down with experts, Dr. Michelle Petri and Dr. Nick Ballew, analyzing the effectiveness of SLE treatments Belimumab and...

12:38Nov 7, 2023

Managing Lupus Nephritis: Importance of Immunosuppression and Mitigation of Tissue Fibrosis

Dr. Anna Wolska from the Lupus Foundation of America interviews Drs. Ana Malvar and Brad Rovin. They discuss using repeat tissue biopsies to...

23:27Oct 2, 2023

Testing a new measure of lupus improvement that encompasses the patients’ perspectives and doctors’ evaluations

Dr. Anna Wolska from the Lupus Foundation of America interviews Drs. Anca Askanase and Joan Merrill, the developers of the LFA-REAL tool. To...

18:05Sep 4, 2023

Understanding Lupus: Exploring the Differences between Type 1 and Type 2 Symptoms

Dr. Anna Wolska from the Lupus Foundation of America interviews Dr. Amrie Grammer and Dr. Peter Lipsky from AMPEL BioSolutions. Together the...

20:25Aug 7, 2023

Unpacking Lupus Treatment: How Quickly Does Anifrolumab Start Working? Insights from TULIP Trials

Dr. Anna Wolska from the Lupus Foundation of America interviews Dr. Ian Bruce, from the University of Manchester in the UK. Dr Bruce discuss...

14:42Jul 3, 2023

Biomarker reduction indicates treatment response to Belimumab

Dr. Anna Wolska from the Lupus Foundation of America interviews Dr. Andrea Fava from Johns Hopkins University about Belimumab treatment in l...

14:35May 24, 2023

Mesenchymal stromal cells: a potential new SLE treatment option?

Duane Peters from the Lupus Foundation of America interviews Dr Gary Gilkeson from the Medical University of South Carolina about a phase I...

17:58Aug 2, 2022

Using patient registries to estimate SLE incidence rate in the USA

Duane Peters from the Lupus Foundation of America interviews Dr Peter Izmirly from New York University and Dr Elizabeth Ferucci from the Ala...

16:53May 26, 2022

Defining remission in systemic lupus erythematosus

Duane Peters from the Lupus Foundation of America interviews Professor Ronald van Vollenhoven from the Amsterdam University Medical Centers...

19:22May 26, 2022

What’s the relationship between self-efficacy and quality of life in SLE patients?

Duane Peters from the Lupus Foundation of America talks to Dr Cristina Drenkard from Emory University and Dr Teresa Brady from Clarity Consu...

20:20Apr 28, 2022

Challenging but achievable: reaching Low Lupus Disease Activity State (LLDAS) in childhood-onset SLE

Duane Peters from the Lupus Foundation of America talks to Dr Sylvia Kamphuis and Dr Javad Wahadat from the Erasmus Medical Center in Rotter...

20:12Apr 6, 2022

Could a high fiber diet positively impact the gut microbiome of SLE patients?

Duane Peters from the Lupus Foundation of America interviews Professor Iryna Kulyk from Indiana University in the USA and Professor Martin K...

15:38Feb 24, 2022

A new biomarker for cognitive dysfunction in SLE?

Duane Peters from the Lupus Foundation of America interviews Dr Erik Anderson and Dr Meggan Mackay from the Feinstein Institutes for Medical...

16:00Jan 27, 2022

Screening for cognitive dysfunction in SLE patients

Duane Peters from the Lupus Foundation of America interviews Jennifer He from the University of Western Ontario in Canada about her research...

16:18Dec 21, 2021

Highlights of ACR Convergence 2021

Duane Peters from the Lupus Foundation of America interviews Dr Jill Buyon, one of LSM's Editors-in-Chief, about the highlights of ACR Conve...

19:00Nov 23, 2021

Personalised metabolite monitoring during pre-conception and pregnancy in SLE patients

Duane Peters from the Lupus Foundation of America interviews Francisca Lambert-Fliszar and Dr Evelyne Vinet from McGill University Health Ce...

18:15Nov 17, 2021

Can you predict lupus nephritis outcomes using machine learning models?

Duane Peters from the Lupus Foundation of America interviews Dr Jim Oates from the Medical University of South Carolina and Ralph H. Johnson...

14:03Oct 22, 2021

Highlights of the LUPUS & CORA 2021 joint congress

Duane Peters from the Lupus Foundation of America interviews Dr Ronald von Vollenhoven, one of LSM's Editors-in-Chief, about the highlights...

16:20Oct 13, 2021

Identifying therapeutic targets in lupus nephritis: is obtaining research tissue via biopsy safe?

Duane Peters from the Lupus Foundation of America interviews Dr Jill Buyon, one of LSM's Editors-in-Chief, and Dr Philip Carlucci from New Y...

20:40Oct 1, 2021

LSM’s first Journal Impact Factor™

Duane Peters from the Lupus Foundation of America interviews the Lupus Science & Medicine Editors-in-Chief, Professor Jill Buyon and Profess...

8:26Aug 31, 2021

Can you conduct clinical trials on lupus patients in a home setting?

Duane Peters from the Lupus Foundation of America interviews Dr Stephen Balevic, Dr Rachel Randell and Professor Laura Schanberg from Duke U...

24:37Jul 2, 2021

EULAR 2021 eCongress Highlights

Duane Peters of the Lupus Foundation of America follows up with Professor Ronald van Vollenhoven of the Amsterdam University Medical Centers...

11:56Jun 8, 2021

Safety profile of anifrolumab in SLE patients

Duane Peters from the Lupus Foundation of America interviews Professor Eric Morand from Monash University in Australia and Dr Raj Tummala fr...

15:06Jun 1, 2021

The ALPHA Project

Duane Peters from the Lupus Foundation of America interviews Dr Susan Manzi from the Allegheny Health Network and Kathleen Arntsen from the...

18:40May 4, 2021

Lupus Academy 10th Annual Meeting Highlights

Duane Peters of the Lupus Foundation of America follows up with Professor Ronald van Vollenhoven of the Amsterdam University Medical Centers...

15:30Apr 22, 2021

Lupus Academy Tenth Annual Meeting Preview

Duane Peters of the Lupus Foundation of America interviews Professor Ronald van Vollenhoven of the Amsterdam University Medical Centers abou...

18:05Apr 8, 2021

Apolipoprotein L1 risk genotypes in Ghanaian patients

Duane Peters from the Lupus Foundation of America interviews Dr Ashira Blazer from New York University, USA, and Dr Ida Dzifa Dey from the U...

17:05Apr 6, 2021

Anti-Müllerian hormone in African- American women with SLE

Duane Peters from the Lupus Foundation of America interviews Ms Meghan Angley and Dr Sam Lim from Emory University in Georgia, and Dr Megan...

17:49Mar 3, 2021

Efficacy and safety of rituximab biosimilar in refractory lupus

Duane Peters from the Lupus Foundation of America interviews Dr Pintip Ngamjanyaporn and Dr Nantakarn Pongtarakulpanit from Mahidol Universi...

13:25Feb 4, 2021

Metabolic syndrome in SLE patients

Duane Peters from the Lupus Foundation of America interviews Dr Diane Apostolopoulos and Dr Eric Morand from Monash Health in Australia abou...

15:00Jan 6, 2021

Validating the use of LFA-REAL to measure disease severity in SLE

Duane Peters from the Lupus Foundation of America interviews Dr Manuel Francisco Ugarte-Gil from Peru and Dr Joan Merrill and Dr Anca Askana...

19:55Dec 16, 2020

ANA testing in SLE and autoimmune rheumatic diseases

Duane Peters from the Lupus Foundation of America interviews Dr May Choi and Dr Peter Schur from the Lupus Program at Brigham and Women's Ho...

12:47Nov 30, 2020

Kynurenine pathway is altered in patients with SLE and associated with severe fatigue

Duane Peters of the Lupus Foundation of America talks to Elisabet Svenungsson and Helena Idborg from Karolinska Institutet about their publi...

12:53Sep 2, 2020